Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 157.9k | $7.55 | $1.2M | | 12/01/2020 |
12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 79.1k | $4.37 | $345.7k | | 12/01/2020 |
12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 150k | $3.93 | $589.5k | | 12/01/2020 |
12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 130.7k | $0.78 | $102.3k | | 12/01/2020 |
12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 40k | $0.97 | $38.9k | | 12/01/2020 |
11/24/2020 | Neurotrope, Inc. | NTRP | Grant | Stock Option (right to buy) | 40k | $0.97 | $38.9k | | 11/24/2020 |
12/13/2019 | Neurotrope, Inc. | NTRP | Grant | Stock Option (right to buy) | 130.7k | $0.78 | $102.3k | | 12/13/2019 |
05/17/2019 | APPLIED DNA SCIENCES INC | APDN | Grant | Stock Option (right to buy) | 175.4k | $0.56 | $98.2k | | 05/17/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Disposition | Option | 15k | $4.70 | $70.5k | | 03/25/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Grant | Option | 15k | $0.75 | $11.2k | | 03/25/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Disposition | Option | 20k | $4.70 | $94k | | 03/25/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Grant | Option | 20k | $0.75 | $15k | | 03/25/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Disposition | Option | 46k | $3.73 | $171.6k | | 03/25/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Grant | Option | 46k | $0.75 | $34.5k | | 03/25/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Disposition | Stock Option | 100k | $3.35 | $335k | | 03/25/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Grant | Stock Option | 100k | $0.75 | $75k | | 03/25/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Disposition | Stock Option | 75k | $1.23 | $92.2k | | 03/25/2019 |
03/25/2019 | BioRestorative Therapies, Inc. | BRTX | Grant | Stock Option | 75k | $0.75 | $56.2k | | 03/25/2019 |
01/22/2019 | Neurotrope, Inc. | NTRP | Grant | Stock Option (right to buy) | 150k | $3.93 | $589.5k | | 01/22/2019 |
12/14/2018 | Neurotrope, Inc. | NTRP | Grant | Stock Option (right to buy) | 79.1k | $4.37 | $345.7k | | 12/14/2018 |
10/29/2018 | BioRestorative Therapies, Inc. | BRTX | Grant | Stock Option | 75k | $1.23 | $92.2k | | 10/29/2018 |
10/17/2018 | APPLIED DNA SCIENCES INC | APDN | Disposition | Stock Option (right to buy) | 12.8k | $5.82 | $74.4k | | 10/17/2018 |
10/17/2018 | APPLIED DNA SCIENCES INC | APDN | Grant | Stock Option (right to buy) | 12.8k | $5.82 | $74.4k | | 10/17/2018 |
03/15/2018 | APPLIED DNA SCIENCES INC | APDN | Grant | Stock Option (right to buy) | 63.9k | $1.57 | $100.4k | | 03/15/2018 |
03/15/2018 | APPLIED DNA SCIENCES INC | APDN | Grant | Stock Option (right to buy) | 7.2k | $1.57 | $11.3k | | 03/15/2018 |
12/14/2017 | Neurotrope, Inc. | NTRP | Grant | | 157.9k | $7.55 | $1.2M | | 12/14/2017 |
06/28/2017 | APPLIED DNA SCIENCES INC | APDN | Grant | Common Stock | 14.2k | $1.76 | $25k | | 06/28/2017 |
06/23/2017 | BioRestorative Therapies, Inc. | BRTX | Grant | Stock Option | 100k | $3.35 | $335k | | 06/23/2017 |
03/01/2017 | BioRestorative Therapies, Inc. | BRTX | Grant | Common Stock | 26.7k | $3.00 | $80k | | 03/01/2017 |
03/01/2017 | BioRestorative Therapies, Inc. | BRTX | Grant | Warrant | 26.7k | $4.00 | $106.7k | | 03/01/2017 |
02/14/2017 | BioRestorative Therapies, Inc. | BRTX | Disposition | Option | 15k | $8.00 | $120k | | 02/14/2017 |
02/14/2017 | BioRestorative Therapies, Inc. | BRTX | Grant | Option | 15k | $4.70 | $70.5k | | 02/14/2017 |
02/14/2017 | BioRestorative Therapies, Inc. | BRTX | Disposition | Option | 20k | $7.00 | $140k | | 02/14/2017 |
02/14/2017 | BioRestorative Therapies, Inc. | BRTX | Grant | Option | 20k | $4.70 | $94k | | 02/14/2017 |
12/20/2016 | APPLIED DNA SCIENCES INC | APDN | Grant | Stock Option (right to buy) | 44.8k | $2.05 | $91.8k | | 12/20/2016 |
|